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Summary: Intestinal ischaemia/reperfusion causes formation of reactive oxygen intermediates which lead to muco-
sal cell injury. Glutathione, a scavenger of reactive oxygen intermediates, protects tissues from reactive oxygen
intermediate-mediated cell injury. Nitric oxide is a lipophilic gas and its synthesis is stimulated by ischaemic
conditions. In this experimental study, we aimed to investigate the role of i. v. L-glutamine infusion on mucosal
tissue glutathione and serum nitric oxide concentrations in intestinal ischaemia/reperfusion. External jugular vein
of albino rabbits was cannulated with catheter and infused with normal saline at 4 ml/h. After 3 days, they were
randomly divided into two main groups. Group 1 (n = 30) received i. v. normal saline alone, group 2 (n = 30)
received normal saline + 205 mmol/1 glutamine at 4 ml/h for 24 hours. Next, mucosal glutathione and serum nitric
oxide concentrations were measured after 0, 30, 60 min of ischaemia/60 min of reperfusion. Basal glutathione
concentrations were similar in normal saline alone and normal saline + 205 mmol/1 glutamine infusion groups
(p > 0.05). At 30 and 60 min of ischaemia/60 min of reperfusion, glutathione concentrations were significantly
lower in normal saline-infused rabbits compared to the normal saline + 205 mmol/1 glutamine-infused rabbits
(p < 0.05). In addition, serum nitric oxide concentrations were found to be significantly increased in rabbits
30 and 60 min after ischaemia/reperfusion when compared to mean basal nitric oxide concentrations obtained
from control animals. However, the normal saline + 205 mmol/1 glutamine group had lower serum nitric oxide
concentrations than did the normal saline alone group. In conclusion, this study revealed that intestinal mucosal
glutathione concentrations were significantly higher in glutamine-receiving rabbits than in non-receiving ones.
Additionally, it was shown that nitric oxide concentrations increased in ischaemia both in normal saline alone
and normal saline + 205 mmol/1 glutamine receiving groups, while this increase in nitric oxide was more
prominent in the normal saline alone group (p < 0.01). These findings show that glutamine supplementation
may protect the small intestine from ischaemia/reperfusion injury and may play a regulatory role in the
biosynthesis of nitric oxide.
Introduction added scavengers might be protective against post-
Multiple organ failure is still the major cause of mortal- ischaemic deterioration (7).
ity in surgical patients and dysfunction is a frequent oc- Glutathione is essential for the protection of endothelial
curence in the cascade of events leading to death (1). cells and gastric chief cells against oxidative stress. Glu-
Bowel injury due to acute intestinal ischaemia continues tathione also has a major role in restoring other free
to be a significant problem. Mortality in a patient with radical scavengers and antioxidants such as vitamins E
this problem approaches 80%, and even when bowel and C to their reduced state (8). The source of oxygen-
ischaemia is reversible, death frequently occurs due to free radicals in the ischaemic small intestine is the en-
multisystem organ failure (2). After prolonged bowel zyme xanthine oxidase (9, 10). However, the Superoxide
ischaemia, cell membrane lipid peroxidation secondary anion and hydrogen peroxide formed can be degraded
to oxygen-free radical injury occurs and may lead to cell by Superoxide dismutase and catalase, respectively, re-
death (3,4). suiting in improved morphologic, anatomic, and cyto-
Intestinal tissue hypoxia is generally accepted to play logic alterations (9> H-13).
the key role in the pathogenesis of mucosal lesions, and Nutritional support specific for the bowel (e. g. gluta-
in local intestinal ischaemia models demonstrated signif- mine) has been shown previously to protect the bowel
icant tissue damage that might occur after restitution of from injury due to abdominal irradiation, chemotherapy,
the intestinal blood flow (4—6). There is much evidence and sepsis (14, 15). Gut I-glutamine requirements are
that oxygen-derived free radicals contribute to the cellu- increased during critical illness, and L-glutamine may
lar damage induced by ischaemia, and that exogenously be essential for the maintenance of gut metabolism,
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structure, and function (15). L-Glutamine is the principle
fuel used by the gastrointestinal tract, with most of the
uptake occurring in small intestinal epithelial cells that
line the villi (16). L-glutamine is necessary for the syn-
thesis of glutathione (2).
Nitric oxide is generated from L-arginine by the action
of the enzyme nitric oxide synthase in vascular and neu-
ral tissues of many organs (17, 18). It has a role in vaso-
dilation and platelet aggregation and acts as an effector
molecule in mediating cytotoxicity (6, 17). Nitric oxide
is a lipophilic gas (17) and its synthesis is stimulated by
endotoxins and ischaemic conditions (19, 20). Although
several studies have shown nitric oxide to be protective
by acting as a vasodilator to prevent long-term isch-
aemia, some studies have suggested that nitric oxide
could contribute to ischaemia/reperfusion injury (21).
While nitric oxide, since it is physiologically a vasodila-
tor, has a role in protecting tissue in ischaemic events,
and since it is chemically a free radical, it may occasion-
ally be harmful to tissue by producing secondary toxic
products. In low tissue O2 saturation conditions, nitric
oxide reduces ischaemic damage by increasing blood
flow secondary to vasodilating effect. In high tissue O2
saturation conditions, it leads toxic metabolites to a cell
by reacting Superoxide and forming some toxic sub-
stances such as peroxynitrite (22).
The aim of this study was to investigate serum nitric
oxide concentrations and mucosal glutathione content of
ischaemic bowel, and whether glutamine prevents pos-
sible tissue damage produced by ischaemia/reperfusion.
Materials and Methods
This study included 60 adult male albino rabbits whose weights
ranged from 1.5 to 3 kg. The rabbits were anaesthetized with keta-
mine hydrochloride injected intraperitoneally (10 mg/kg weight).
After anaesthesia, the external jugular vein was cannulated with a
catheter that was tunnelled subcutaneously, brought through the
skin posteriorly between the scapulas, passed through a stainless
steel catheter guard, and attached to a swivel on a runner above
the animal cage. Through the catheters, normal saline at 4 ml/h was
infused using a microinfusion pump. Following recovery, rabbits
were allowed to drink water and to eat a regular diet. After 3 days,
they were randomly divided into two main groups. Group 1
(n = 30) received i. v. normal saline alone, group 2 (n = 30) re-
ceived normal saline +3% (205 rnmol/1) glutamine at 4 ml/h for
24 hours. Both of the groups were again divided into 3 subgroups,
each containing 10 rabbits (10 exposed to 0, 10 to 30 and 10 to 60
min of ischaemia). The rabbits that underwent a sham-operation
were taken as the control group.
After that, each animal was reanaesthetized and underwent midline
abdominal opening. Next, the superior mesenteric artery was ex-
posed. After a half-hour wait, for the production of intestinal isch-
aemia, the superior mesenteric artery was acutely occluded with a
vascular clamp for 0, 30 or 60 min. In each animal, the ischaemic
period was followed by 60 minutes of intestinal reperfusion. Then,
the small intestine was excised and opened longitudinally scarping
with a spatula. Following small bowel resection the animals were
sacrified until which i. v. infusion of normal saline or normal saline
+ 205 mmol/1 glutamine was continued. Blood samples for nitric
oxide measurement were taken after the ischaemia/reperfusion
period, (at 0, 30 and 60 min) and centrif ged at 2500 g for 10
minutes. Both mucosa and serum samples were frozen and stored
at -70 °C until analyzed.
Analytical procedures
Total glutathione concentrations in the small intestine were as-
sessed according to the method of Griffith (23). Briefly, 0.5 g of
sample taken from small intestine was homogenized in a dilution
reagent containing triton X-100 (volume fraction 0.05) and
1 mmol/1 EDTA. After centrifugation at 10 000 g for 10 min at
4 °C, 400 μΐ of supernatant, 700 μΐ 0.3 mmol/1 NADPH, 100 μΐ
6 mmol/1 5,5'-dithiobis (2-nitrobenzoic acid) and 500 μΐ buffer (0.2
mol/1 sodium phosphate plus 10 mmol/1 EDTA, pH: 7.5) were
mixed carefully in a cuvette. Then 10 μΐ of glutathione reductase
were added and incubated 10 min at room temperature. The absor-
bance of colour developed was detected at 412 nm. The results
were presented as μηιοΐ/g wet tissue. Tests were performed in
duplicate.
For the determination of nitric oxide concentrations, the serum
samples obtained were deproteinized with sulphosalicylic acid
(1.377 mol/1). Then, nitrate (NO^) in a supernatant was reduced
by cadmium column (100 mesh) to nitrite (NO;f) and the concen-
tration of NO2" was determined with the Griess reaction (24). In
this reaction, the Griess reagent consisted of one part 0.004 mol/1
naphthylenediamine dihydrochloride and one part 0.057 mol/1
sulphanilamide in 0.131 mol/1 phosphoric acid, mixed together and
kept chilled. After incubation in a waterbath at 60 °C, the colour
of the product dye was developed and its absorbance was detected
at 560 nm using a spectrophotometer (Shimadzu, Japan). Each
sample was studied in duplicate. Standards of sodium nitrite and
sodium nitrate from 10 to 60 μπιοΐ/ΐ.
Statistical analysis
Data are represented as mean ± standard deviation. Statistical
comparisons were performed using the ANOVA and linear regres-
sion analysis. Statistical significance was defined with a p < 0.05.
Results
Tissue glutathione concentrations were similar in the
normal saline alone and in normal saline + 205 mmol/1
glutamine infusion groups that did not undergo isch-
aemia/reperfusion injury (p > 0.05). In animals receiv-
ing normal saline alone and normal saline + 205 mmol/1
glutamine exposed to 30 and 60 min of ischaemia, both
followed by 60 min of reperfusion, tissue glutathione
concentrations were found to be lower compared to the
controls. In addition, tissue glutathione concentrations
were significantly higher in normal saline + 205 mmol/1
glutamine than in the normal saline alone group at 30
and 60 min of ischaemia/reperfusion (tab. 1).
For serum nitric oxide values, there was no difference
between the animals not exposed to ischaemia in either
normal saline alone or normal saline + 205 mmol/1 glu-
tamine groups (p > 0.05). In both groups serum nitric
oxide levels were found to be significantly increased in
rabbits that underwent 30 and 60 min of ischaemia when
compared to mean basal nitric oxide concentrations ob-
tained from control animals. However, the normal saline
+ 205 mmol/1 glutamine group had lower serum nitric
oxide concentrations than did the normal saline alone
group (tab. 2).
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Tab. 1 Mucosal tissue glutathione concentrations (μιηοΐ/g wet weight)
Duration of ischaemia
30 60
Normal saline 4.16 ± 0.64a





p < 0.001: a vs c, a vs e, b vs f; p < 0.01: b vs d; p < 0.05: e vs d, e vs f
Tab. 2 Serum nitric oxide concentrations (μηιοΐ/ΐ)
Duration of ischaemia
30 60
Normal saline 23.60 ± 5.7la





ρ < 0.001: a vs c, a vs e; ρ < 0.01: b vs d, b vs f, c vs d, e vs f
In each group, glutathione and nitric oxide values at 30
and 60 min of ischaemia were not statistically different
(p > 0.05). On correlation analysis, no significant rela-
tion was detected between nitric oxide and glutathione
values in any group.
Discussion
Glutathione is a tripeptide consisting of glutamate, cys-
teine, and glycine and under various experimental condi-
tions, the glutamate portion of the molecule is derived
from glutamine (10). L-glutamine is a major antioxidant
and a vital component of host defences (6, 10). The
small intestine extracts approximately 25% of circulat-
ing Z-glutamine (16). The bonding of glutamate with
cysteine is the rate-limiting step in the synthesis of glu-
tathione, and it has been shown that depletion of gluta-
mate leads directly to a decrease in cell glutathione
content, suggesting that an adequate supply of Z,-gluta-
mine is important for the synthesis of glutathione (2).
Total glutathione concentrations are known to pro-
gressively decrease with increasing duration of isch-
aemia (8). While during reperfusion, total glutathione
concentrations slowly increase back toward baseline
concentrations. In addition, it has been found that the
severity of ischaemia/reperfusion cell injury is inversely
proportional to the cell's pre-ischaemia total glutathione
content (2, 7, 8). In Stein (8) and Hirota et al.'s (25)
studies, they claimed that pretreatment with glutamine
did not increase mucosal glutathione levels in the con-
trol group but protected against the ischaemia/reperfu-
sion-induced drop in endogenous glutathione, which
paralleled the development of mucosal injury in gluta-
thione-depleted animals. These reports strongly support
the important protective function of glutathione during
reperfusion of ischaemic tissue.
Nutritional supplementation of L-glutamine can assist in
protecting the small bowel during a variety of pathologic
states (2). Glutamine is the main fuel used by the intesti-
nal tract (16) but is absent from currently available
amino acid solutions and many enteral diets (26). Oral
administration of glutamine increases the glutathione
concentrations of jejunal and colon mucosa and protects
these tissue against L-buthionine-sulphoximine induced
glutathione. This suggests that oral administration might
be of therapeutic value in inflammatory disease, isch-
aemia, oxidative damage, chemotherapy, and radiation
(26). Addition of alanyl glutamine dipeptide to the total
parenteral nutrition solution improves intestinal L-gluta-
mine metabolism and prevents mucosal atrophy and de-
terioration of permeability. In experimental animal mod-
els, the addition of free L-glutamine and glutamine di-
peptide to total parenteral nutrition solution demon-
strated a beneficial effect on intestinal morphology (16).
The etiology of bowel wall protection provided by gluta-
mine is unclear, and may be due to maintenance of the
cell antioxidant defence system. Ionizing radiation and
some chemotherapeutic agents injure cells by increasing
tissue oxidant activity. These data suggest that glutamine
provides protection during oxidant injury by helping to
maintain cell glutathione concentrations. Ziegler et al.
(27) reported that L-glutamine supplementation im-
proved nutritional status and shortened the hospital stay
of patients with bone marrow transplantation. Harward
et al. (2) studied intestinal ischaemia/reperfusion after
I-glutamine supplementation and found an increased in-
testinal glutathione content. We also detected that intes-
tinal mucosal glutathione concentrations were found to
be higher in the normal saline + 206 mmol/1 glutamine
group than in the normal saline alone group at 30 and 60
min of ischemia/reperfusion, so glutamate concentration
increased and that led to increased glutathione concen-
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trations in the normal saline + 205 mmol/1 glutamine
infused rabbits when compared to the normal saline
alone group. Glutathione concentrations both at 30 and
60 minutes of ischaemia/reperfusion were found to be
lower in normal saline alone and normal saline + 205
mmol/1 glutamine infused groups when compared to
control groups. This finding was in agreement with the
studies mentioned above. Glutathione concentrations
increased to minimize the damage of increased free radi-
cals produced during ischaemia/reperfusion. L-Gluta-
mine, which is more easily transportable across cell
membranes than glutamate, serves as the intracellular
source of glutamate. L-Glutamine is deaminated in the
mitochondria to glutamate and NH3. Glutamate is then
transported back to the cytosol where it is readily avail-
able for glutathione synthesis (10).
Studies have implicated nitric oxide as a mediator, mes-
senger, or regulator of cell function in physiologic states
that include vascular tone, platelet function, septic shock
(19). Masuda et al. (28) have demonstrated that endoge-
nous nitric oxide may be an essential protective factor
in the pathogenesis of ethanol-induced gastric mucosal
injury through improved mucosal haemodynamics.
There is a alternative explanation of the protective
mechanism of nitric oxide — may function as a chemical
barrier to cytotoxic free radicals because nitric oxide
could be a natural extracellular scavenger of Ο^~. It
seems that Superoxide radicals, possibly from endothe-
lial cells themselves and/or Kupffer cells, contribute to
the endothelial cell injury (6). The nitric oxide radical is
increasingly recognized as an important intra- and inter-
cellular messenger that is identical to endothelium-de-
rived relaxing factor and is the principal signal for relax-
ation of vascular smooth muscle cells. A role for nitric
oxide has been implicated in a variety of biological pro-
cesses such as neutrotransmission, tumour cell killing,
immunity, and inflammatory processes. Both cytopro-
tective and cytotoxic effects of nitric oxide have been
reported (29). Nitric oxide is important in the regulation
of mucosal blood flow, acid secretion and mucus secre-
tion and contributes to mucosal protection of the stom-
ach (29). Takeuchi et al. (30) showed that the inhibition
of endogenous nitric oxide production stimulates duode-
nal HCO^ secretion and rather protects the duodenal
mucosa from damage caused by the duodenal ulcero-
gen, mepirizole.
In the present study, serum nitric oxide concentrations
both at 30 and 60 minutes of ischaemia/reperfusion were
found to be higher in normal saline alone and normal
saline + 205 mmol/1 glutamine infused groups when
compared to controls. However, serum nitric oxide val-
ues of the normal saline + 205 mmol/1 glutamine group
were lower than those of the normal saline alone group.
According to Sessa et al., this decrease shows that L-
glutamine is the inhibitory principle present in culture
medium that prevents the intracellular generation of L-
arginine and inhibits the release of endothelium-derived
relaxing factor from cultured endothelial cells (31). In
these two groups, the increase in nitric oxide concentra-
tions may be secondary to the free radicals produced
during ischaemia/reperfusion. Decrease in nitric oxide
concentrations in the normal saline + 205 mmol/1 gluta-
mine group compared to the normal saline alone group
may be explained as follows: glutamine infusion may
lead to increased production of glutathione that protects
the tissue being exposed to ischaemia/reperfusion from
oxygen radicals, thus nitric oxide production may be
rather less in the glutamine-infused group.
In conclusion, this study revealed that intestinal mucosal
glutathione concentrations were significantly higher in
glutamine-receiving rabbits than in non-receiving ones.
Additionally, it was shown that nitric oxide concentra-
tions increasing in ischaemia. Nitric oxide concentra-
tions were high in the glutamine-receiving group but
lower than those of the normal saline group. These find-
ings show that glutamine supplementation may protect
the small intestine from ischaemia/reperfusion injury.
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